Solence, a Paris-based health startup, raised €1.6M in seed funding to support women with Polycystic Ovary Syndrome (PCOS). Founded in 2022 by Clara Stephenson, Solence aims to provide tools for managing chronic conditions tied to PCOS through lifestyle programs and AI. The startup targets the insufficient support experienced by 85% of the 20% of women globally living with this condition. Solence's digital app offers a twelve-week program that promotes necessary lifestyle modifications, addressing gaps in traditional care that heavily relies on medication.
Solence develops tools for managing chronic conditions linked to PCOS, using lifestyle programs and AI systems to support patients and improve care access.
PCOS affects up to 20% of women globally, yet 85% lack adequate support. Solence aims to improve their quality of life through innovative digital solutions.
Collection
[
|
...
]